@windhamvp

Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test

Receives Breakthrough Device Designation from the Food and Drug Administration Announces Partnership with NYU Langone to Investigate Test in Additional Populations BALTIMORE, March 31, 2021 /PRNewswire/ — Delfi Diagnostics, Inc., a pioneering developer … Continued

ChromaCode Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition

CARLSBAD, Calif., March 16, 2021 /PRNewswire/ — ChromaCode, Inc. today announced that the company has been selected as a Main Track Winning Team in the XPRIZE Rapid COVID Testing competition, which aims to … Continued

Growing Medication Management Optimization Company, Cureatr, Names New Executive Leadership

Cureatr, Inc. expands executive leadership team to address rapid expansion of its tech-enabled clinical telepharmacy services NEW YORK–(BUSINESS WIRE)–Cureatr, Inc., a medication management optimization technology and services company, has experienced … Continued

ControlRad® Announces FDA Clearance for ControlRad Select

ATLANTA, March 4, 2021 /PRNewswire/ — ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, has announced the U.S. Food and … Continued

Upward Health Announces Significant Growth Equity Investment Led by Heritage Group

March 02, 2021 09:12 AM Eastern Standard Time PROVIDENCE, R.I.–(BUSINESS WIRE)–Upward Health, a leading home-based medical group that specializes in high-risk, high-need populations, today announced that it raised a significant … Continued